Petros Pharmaceuticals, Inc. (PTPI) stock
PTPIOTCPharmaceutical PreparationsFiscal year ends December 31
$0.00+0.00 (+5.56%)
Close on Oct 19, 2026Market cap $135.07KP/E –Yield –
Petros Pharmaceuticals revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Petros Pharmaceuticals's revenue for the twelve months ending Dec 31, 2024 was $5.11M. For fiscal 2024 it was $5.11M, down 12.2% from the year before. The highest annual figure on record is $9.56M in fiscal 2020.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $5.11M | -12.2% |
| FY2023 | Dec 31, 2023 | $5.82M | -2.8% |
| FY2022 | Dec 31, 2022 | $5.99M | -23.3% |
| FY2021 | Dec 31, 2021 | $7.81M | -18.3% |
| FY2020 | Dec 31, 2020 | $9.56M | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2024 | Dec 31, 2024 | $725.40K | -56.7% |
| Q3 FY2024 | Sep 30, 2024 | $1.58M | -20.9% |
| Q2 FY2024 | Jun 30, 2024 | $1.42M | -43.5% |
| Q1 FY2024 | Mar 31, 2024 | $1.39M | +74.0% |
| Q3 FY2023 | Sep 30, 2023 | $1.67M | -60.0% |
| Q2 FY2023 | Jun 30, 2023 | $1.99M | -19.1% |
| Q1 FY2023 | Mar 31, 2023 | $2.52M | +2.5% |
| Q4 FY2022 | Dec 31, 2022 | $798.10K | -80.4% |
| Q2 FY2022 | Jun 30, 2022 | $4.19M | +42.9% |
| Q1 FY2022 | Mar 31, 2022 | $2.47M | -28.8% |
| Q2 FY2021 | Jun 30, 2021 | $2.46M | +78.9% |
| Q1 FY2021 | Mar 31, 2021 | $4.08M | +127.4% |
| Q4 FY2020 | Dec 31, 2020 | $2.93M | – |
| Q3 FY2020 | Sep 30, 2020 | $3.46M | – |
| Q2 FY2020 | Jun 30, 2020 | $1.37M | – |
| Q1 FY2020 | Mar 31, 2020 | $1.79M | – |
See a number that looks wrong?